baber/WOPTO huggingface dataset:
Patent JP-2798330-B2 (JP)
IPC: H05K1/02
Filed: 1992-10-09
Granted: 1998-09-17
Abstract: PURPOSE:To prevent an output from being defective by dust such as a glass fiber generated from a substrate. CONSTITUTION:A glass cover 2 is fitted to the upper part of a frame 1, a light source substrate 4 mounting a light emitting element 3 is fixed inside the frame 1, and a rod lens array 5 is fixed. A sensor substrate 7 mounting a light receiving element 6 is arranged at the lower part of the frame 1, and positioning holes 7a and 7b are bored on the both sides of the sensor substrate 7 in the lengthwise direction. Pins 1a and 1b are provided projectingly at the lower part of the frame 1 corresponding to these holes 7a and 7b and further, the holes 7a and 7b are coated with friction reducing films for preventing friction with the pins 1a and 1b.
Patent JP-2708357-B2 (JP)
IPC: G06F12/00
Filed: 1993-11-04
Granted: 1998-02-04
Abstract: A transaction network in which, in appropriate cases, a transaction is allowed to complete at each node and new work to commence, before all transaction resources at the node actually complete a syncpoint operation. This desirable result is obtained without the risk of unreported database corruption. At each node in response to a prepare to commit syncpoint command from a parent node, the node in question determines if it or any of its descendant nodes can make a unilateral heuristic decision to commit or backout the transaction irrespective of whether or not the final syncpoint command is to commit or backout. Each node informs its parent node that it is reliable or unreliable. Reliable means that neither this node nor any of its descendant nodes can make a unilateral heuristic decision. Unreliable means that this node or one or more of the descendant nodes may make such a unilateral decision. If a node is reliable, the transaction is released at the node after receiving and propagating to descendant nodes the final commit or backout command and before completion or acknowledgement of completion of the commit or backout command by the node or any of its descendant nodes. If the node is unreliable, then it waits for acknowledgement of completion of the commit or backout syncpoint operation at all unreliable nodes, including itself, before releasing the transaction at the node.
Patent JP-2568230-B2 (JP)
IPC: A61K9/20
Filed: 1987-12-01
Granted: 1996-12-25
Abstract: A controlled release pharmaceutical composition comprising a plurality of film coated spheroids, the film coated spheroids comprising a 3-alkylxanthine, a non-water soluble spheronising agent and between 4% and 9% (by weight) water, wherein the in-vitro dissolution rate of the 3-alkylxanthine from the film coated spheroids, when measured by the USP Paddle Method at 100rpm in 900ml aqueous buffer (pH 6.5 at 37 DEG C) is between 7.5% and 25.0% (by wt) release after 1 hour, between 22.5% and 45.0% (by wt) release after 2 hours, between 40.0% and 60.0% (by wt) release after 3 hours, between 50.0% and 75.0% (by wt) release after 4 hours, between 70.0% and 92.5% (by wt) release after 6 hours, and between 80.0% and 100.0% (by wt) release after 8 hours. Preferably the water content is between 4% and 8%, especially between 4% and 7% (by wt) of the film coated spheroid formulation. The preferred 3-alkylxanthine is theophylline (anhydrous or hydrate), whilst the preferred spheronising agent is microcrystalline cellulose.
Patent JP-3419181-B2 (JP)
IPC: B29K69/00
Filed: 1995-11-13
Granted: 2003-06-23
Abstract: A thermoplastic polycarbonate molding composition free from organo phosphorus compounds and having an improved resistance to discoloration caused by exposure to High Intensity Discharge (HID) light and heat is disclosed. Accordingly, the molding composition contains (co)polycarbonate resin, a dimeric benzotriazole and an ester of a 3,5-di-tert-butyl-4-hydroxyhydrocinnamic acid. In a preferred embodiment, a sheet made of (co)polycarbonate resin is rendered improved resistance to discoloration by having applied to at least one of its surfaces an adherent protective film prepared from the polycarbonate composition of the invention.
Patent JP-2525841-B2 (JP)
IPC: C04B35/10
Filed: 1987-12-22
Granted: 1996-08-21
Abstract: The present invention provides a method for producing a self-supporting ceramic composite by the oxidation of a parent metal (10) to form a polycrystalline ceramic material consisting essentially of the oxidation reaction product of the parent metal (10) with an oxidant, including a vapor-phase oxidant, and, optionally, one or more metallic constituents. A permeable filler material, such as a preform (14), with at least one surface bearing a permeble stratum (18), is contacted with a body of molten parent metal (10) heated to a temperature above its melting point but below the melting point of the oxidation reaction product. At least a portion of the oxidation reaction product is maintained in contact with and between the molten metal (10) and oxidant to transport the molten metal through the oxidation reaction product toward the permeable stratum (18) and into contact with the oxidant so that the oxidation reaction product continues to form at the interface between the oxidant and previously formed oxidation reaction product that has infiltrated the filler material. The reaction is continued to infiltrate at least a portion of the stratum (18) with the oxidation reaction product and to produce an intermediate ceramic body having an adjacent ceramic composite overlaid with a ceramic stratum. The ceramic stratum is removed from the underlying ceramic composite to produce a self-supporting ceramic composite having the surface established by the permeable stratum (18).
Patent JP-3989025-B2 (JP)
IPC: F04D29/44
Filed: 1998-05-28
Granted: 2007-10-10
Abstract: A circulation pump for pumping a fluid, for example for heat interchange, by way of a rotating impeller is included in a circulation system that includes a first feeder liner from a heat source to a cooling device, a return line from the cooling device to the pump and a valve for shunting the outflow from the heat source via a bypass line back to the pump. The bypass line is connected to the pump in such a way that a flow essentially from this line produces and/or increases a pre-rotation of the inflow to the impeller, which pre-rotation results in a reduction of the power required by the engine.
Patent JP-H0423004-B2 (JP)
IPC: A42C2/00
Filed: 1985-06-14
Abstract: PCT No. PCT/CH85/00098 Sec. 371 Date Feb. 14, 1986 Sec. 102(e) Date Feb. 14, 1986 PCT Filed Jun. 14, 1985 PCT Pub. No. WO86/00198 PCT Pub. Date Jan. 16, 1986.This helmet comprises an outer protective shell, an impact-absorbing layer made from a non-elastically compressible material, and a layer of elastically compressible material. A dome is interposed between the said layer and the impact-absorbing layer. The said dome is obtained by hot-drawing a 0.3 to 0.7 mm sheet material, of which the modulus of elasticity is between 1800 and 3500 N/mm2, the elongation at rupture less than 100% and the ultimate tensile strength between 30 and 100 N/mm2.
Patent JP-2710375-B2 (JP)
IPC: C08B37/00
Filed: 1988-04-06
Granted: 1998-02-10
Abstract: An antacid composition which comprises   a) a substance which is soluble in water at a neutral or alkaline pH, but which is capable of forming a cohesive gel at an acid pH, b) a substance which is capable of acting as a buffer and which is capable of being captured in the gel structure formed by substance a) at an acid pH, and c) one or more acid neutralising agents capable of being trapped in the gel structure formed by substance a) at an acid pH, at least one of which causes the gel to foam when contacted with an acid,   the composition being formulated so that substance a) is dissolved before ingestion of the composition and having raft-forming properties in a gastric environment.
Patent JP-3415836-B2 (JP)
IPC: A63B47/00
Filed: 1992-01-16
Granted: 2003-06-09
Abstract: A game ball assembly for use with a game ball is described comprising a net for receiving and holding the game ball, a handle adapted to be retained within a user's hand, a length adjuster having a body part and a relatively movable locking slide part defining with said body part two paths at opposite sides of the slide part, and an elongated substantially inelastic tether cord or rope secured between the handle and the net. The tether extends through one of the paths of the length adjuster, through the net and then through the other path of the length adjuster such that a free end of the tether is supported between the slide part and the body part of the length adjuster. This arrangement facilitates simple adjustment of the length of the tether.
Patent JP-2828175-B2 (JP)
IPC: A61M5/178
Filed: 1990-03-20
Granted: 1998-11-25
Abstract: This invention relates to a safety syringe needle device which has medical and industrial application. More particularly, this invention pertains to a syringe which, after being used by a person to inject medication or fluid into a patient, or in sampling or exposure to toxic materials, or the like, can be transformed by the person to withdraw the needle into the barrel of the syringe for disposal purposes, thereby eliminating needlestick injuries among such persons. A syringe comprising (a) a hollow elongated barrel means; (b) penetration means which is adapted to removably engage with an end of the barrel means; (c) plunger means adapted to fit within and move axially in the hollow barrel means; the plunger means causing a pumping action within the interior of the barrel means between the plunger means and the end of the barrel means when the plunger means is pushed into the interior of the barrel means in the direction of the end of the barrel means; and (d) engaging means at the end of the plunger means proximate to the penetration means, the engaging means being adapted to engage the end of the penetration means when the plunger means is fully inserted into the interior of the barrel means in the direction of the end of the barrel means and cause the penetrating means to part from the end of the barrel means and to be withdrawn into the interior of the barrel when the plunger means is withdrawn away from the end of the barrel means. An adapter for a syringe having a piston and a needle base fitting in the end of the syringe comprising: (a) a protrusion formed at one end of the adapter for fitting inside the hollow of a base affixed to a syringe needle; (b) releasable engagement means formed in the exterior of the adapter and being adapted to releasably engage with the interior of the needle receiving end of a syringe barrel; and an engagement means formed in the end of the adapter opposite the protrusion, said engagement means being adapted to engage with the piston end of a syringe plunger.
Patent JP-3007992-B2 (JP)
IPC: A61P15/00
Filed: 1994-08-10
Granted: 2000-02-14
Abstract: PCT No. PCT/EP94/02697 Sec. 371 Date Feb. 21, 1996 Sec. 102(e) Date Feb. 21, 1996 PCT Filed Aug. 10, 1994 PCT Pub. No. WO95/05822 PCT Pub. Date Mar. 2, 1995The R(+) isomer of amlodipine is a potent inhibitor of smooth muscle cell migration despite its lack of calcium channel-blocking activity. It is useful for treating atherosclerosis, re-stenosis after angioplasty and endometriosis.
Patent JP-3901737-B2 (JP)
IPC: G01J3/45
Filed: 1997-08-01
Granted: 2007-04-04
Abstract: A double-beam interferometer for electromagnetic radiation and a method for the compensation of dispersion or increase in the spectral resolution of such an interferometer. Using a polarizer, which is brought into the optical radiation path, a defined polarization state P½0 is produced for the electromagnetic partial waves flowing into the arms of the interferometer. This polarization state is wavelength-independent and can vary for both partial beams. Optical elements modify the polarization state P½0 of the electromagnetic partial waves as a function of wavelength lambd and each spectral component lambdi is coded with a polarization P½ (lambdi). An analyzer, fitted to the output of the interferometer, transmits an adjustable polarization state Pdet, whereby an additional wavelength-dependent phase difference gamma(lambd) occurs between the partial waves of the spectral components. gamma(lambd) can be adjusted to obtain compensation of dispersion or an increase in the spectral resolution of the interferometer.
Patent JP-2888988-B2 (JP)
IPC: A61P25/00
Filed: 1995-05-18
Granted: 1999-05-10
Abstract: PCT No. PCT/IB95/00380 Sec. 371 Date Feb. 13, 1996 Sec. 102(e) Date Feb. 13, 1996 PCT Filed May 18, 1995 PCT Pub. No. WO96/06081 PCT Pub. Date Feb. 29, 1996This invention relates to compounds of formula (I), or pharmaceutically acceptable acid addition salts thereof, wherein: (a) R2 and R5 are taken separately and R1, R2, R3 and R4 are each independently hydrogen, (C1-C6) alkyl, halo, CF3, OH or OR7 and R5 is methyl or ethyl; or (b) R2 and R5 are taken together, forming a chroman-4-ol ring, and R1, R3 and R4 are each independently hydrogen, (C1-C6) alkyl, halo, CF3, OH or OR7; and R6 is a substituted piperidinyl, pyrrolidinyl or 8-azabicyclo(3.2.1)octanyl derivative; provided that (a) when R2 and R5 are taken separately, at least one of R1, R2, R3 and R4 is not hydrogen; and (b) when R2 and R5 are taken together, at least one of R1, R3 and R4 is not hydrogen; pharmaceutical compositions thereof; and methods of treating mammals suffering from stroke, spinal cord trauma, traumatic brain injury, multiinfarct dementia, CNS degenerative diseases such as Alzheimer's disease, senile dementia of the Alzheimer's type, Huntington's disease, Parkinson's disease, epilepsy, amyotrophic lateral sclerosis, pain, AIDS dementia, psychotic conditions, drug addictions, migraine, hypoglycemia, anxiolytic conditions, urinary incontinence and an ischemic event arising from CNS surgery, open heart surgery or any procedure during which the function of the cardiovascular system is compromised with a compound of formula (I) hereinabove or a pharmaceutically acceptable salt thereof.
Patent JP-3638599-B2 (JP)
IPC: C12R1/66
Filed: 1993-10-06
Granted: 2005-04-13
Abstract: (A) An isolated DNA sequence of a sec1 suppressor gene SSO or a homologue is claimed, which DNA sequence, when overexpressed in eukaryotic cells, renders the cells capable of producing increased amts. of secreted proteins. Also claimed are: (B) a vector comprising a DNA sequence as in (A); and (C) recombinant eukaryotic cells carrying a DNA sequence as in (A) and expressing enhanced levels of SSO protein.
Patent JP-3992290-B2 (JP)
IPC: C12P21/08
Filed: 1990-05-16
Granted: 2007-10-17
Abstract: The present invention relates to a method for isolating from the immunological repertoire a gene coding for a receptor having the ability to bind a preselected ligand. Receptors produced by the gene isolated by the method, particularly catalytic receptors, are also contemplated. <IMAGE>
Patent JP-3665905-B2 (JP)
IPC: C12N15/61
Filed: 1993-10-08
Granted: 2005-06-29
Abstract: PCT No. PCT/NO93/00151 Sec. 371 Date May 9, 1995 Sec. 102(e) Date May 9, 1995 PCT Filed Oct. 8, 1993 PCT Pub. No. WO94/09124 PCT Pub. Date Apr. 28, 1994DNA compounds encompassing sequences coding for enzymes having mannuronan C-5-epimerase activity are disclosed and a process for the preparation of such enzymes. The genetic sequences and enzymes prepared may be used in the production of alginates having a definite G/M ratio and block structure. Alginates having a definite G/M ratio may also be produced by selective inactivation of the genetic sequences.
Patent JP-3606867-B2 (JP)
IPC: F03C99/00
Filed: 1993-10-22
Granted: 2005-01-05
Abstract: PCT No. PCT/AU93/00547 Sec. 371 Date Apr. 21, 1995 Sec. 102(e) Date Apr. 21, 1995 PCT Filed Oct. 22, 1993 PCT Pub. No. WO94/10452 PCT Pub. Date May 11, 1994An engine for driving a piston arrangement for pumping water from an inlet to an outlet at a higher level is disclosed. The engine includes a hollow housing having an inlet and an outlet between which liquid passes, the housing at least partly enclosing a chamber through which the liquid flows from the inlet to the outlet. A movable wall is mounted in the housing and partly defines the chamber. A valve is provided to open and close the outlet so that when it closes, liquid in the chamber is suddenly decelerated producing an increase in pressure in the chamber to force the wall to move to a direction so as to increase the volume of the chamber. After an initial increase in the pressure, the water relaxes and the pressure decreases to such an extent that a spring will open the valve and the spring returns the wall to the position of decreased volume in the chamber. Thus, the wall is caused to reciprocate under the influence of pressure of the liquid increasing and decreasing as the valve is opened and shut.
Patent JP-2961708-B2 (JP)
IPC: A61K47/10
Filed: 1991-05-31
Granted: 1999-10-12
Abstract: PCT No. PCT/US93/10259 Sec. 371 Date Nov. 19, 1993 Sec. 102(e) Date Nov. 19, 1993 PCT Filed Oct. 26, 1993 PCT Pub. No. WO91/18621 PCT Pub. Date Dec. 12, 1991A method is disclosed for treating obese mammals or preventing obesity from occurring in mammals. This method involves administering to the mammal an effective amount of growth hormone in combination with an effective amount of IGF-I. Preferably, the growth hormone is given so as to have a maintained, continual therapeutically effective presence in the blood, such as by continuous infusion or frequent injections, or by use of a long-acting formulation.
Patent JP-2951399-B2 (JP)
IPC: C07C255/53
Filed: 1990-08-14
Granted: 1999-09-20
Abstract: Disclosed are certain poly-methine compounds having the formula <CHEM> wherein each R<1> is independently selected from cyano; carboxy; alkenyloxycarbonyl; an unsubstituted or substituted alkoxycarbonyl, cycloalkoxycarbonyl or aryloxycarbonyl radical; an unsubstituted or substituted, carbocyclic or heterocyclic aryl radical; an unsubstituted or substituted alkanoyl, cycloalkanoyl or aroyl radical; an unsubstituted or substituted carbamoyl radical; or an unsubstituted or substituted alkylsulfonyl, cycloalkylsulfonyl or arylsulfonyl radical; each R<2> is independently selected from cyano or an unsubstituted or substituted alkoxycarbonyl, cycloalkoxycarbonyl or aryloxycarbonyl radical; each A is independently selected from an unsubstituted or substituted 1,2-phenylene or 1,2-naphthylene radical; each Z is independently selected from -O- or -S-; and L is an organic linking group bonded by non-oxo carbon atoms to each Z atom. Also disclosed are sunscreen formulations and polymeric compositions containing at least one of the poly-methine compounds or the reactive residue thereof.
Patent JP-4303789-B2 (JP)
IPC: C11D3/382
Filed: 1997-03-15
Granted: 2009-07-29
Abstract: Glassy particles containing agents useful for laundry and cleaning products (preferably perfumes, bleaching agents, soil release polymers), and laundry and cleaning products containing these glassy particles. The particles comprise a glass derived from one or more at least partially water-soluble hydroxylic compounds, such as hydrogenated starch hydrolysates, sucrose, glucose, and starch hydrolysates. The glassy particle also has a hygroscopicity value of less than about 80 %.
Patent JP-4450434-B2 (JP)
IPC: H04N7/171
Filed: 1996-10-17
Granted: 2010-04-14
Abstract: The circuit, to counter copy protection signals in a video signal, includes a protection detection circuit and a generic modification circuit. The copy protected video signal (12) is input to a correction circuit (14) and to a detector. This has a chroma band pass amplifier (16) to separate the chrominance and the luminance signals. An envelope detector (20) senses the lines containing the colour bursts, and triggers a one-shot circuit (22) having a period of about 52 microseconds, which is less than one TV line period. A second trigger circuit generates a 70 microsecond pulse. These triggers are applied to an AND circuit whose output causes the correction circuit to counter the copy protect signals.
Patent JP-3495736-B2 (JP)
IPC: C08K5/06
Filed: 1995-12-13
Granted: 2004-02-09
Abstract: An improved process for preparing free flowing tetrafluoroethylene (TFE) polymer powders is disclosed in which a TFE polymer powder is (1) wetted with an aqueous solution containing a wetting agent selected from the group consisting of (a) ethylene glycol ethers, (b) propylene glycol ethers and (c) diols or triols, (2) agglomerated and (3) dried.
Patent JP-3724811-B2 (JP)
IPC: B01L3/00
Filed: 1997-01-24
Granted: 2005-12-07
Abstract: Medical diagnostic test strips having a desiccant deposit applied directly to the test strip. Moisture barrier sheets cover the test strip. Alternatively, the moisture barrier sheets have a desiccant deposit attached to them. Also alternatively, a pouch with a desiccant deposit attached to its inner surface contains the test strip.
Patent JP-3948751-B2 (JP)
IPC: A61K39/00
Filed: 1997-02-13
Granted: 2007-07-25
Abstract: A vaccine comprising a liposome preparation including at least one B-cell malignancy-associated antigen, IL-2, alone or in combination with at least one other cytokine, and at least one type of lipid molecule, is useful in a method of inducing humoral and cellular immune responses against malignant B-cells in a mammal.
Patent JP-3992113-B2 (JP)
IPC: A61B5/00
Filed: 1998-01-09
Granted: 2007-10-17
Abstract: A method for compiling data characteristic of a sample of material, comprising the steps of: sequentially illuminating, with an optical assembly, a plurality of volume elements in said sample by directing electromagnetic radiation into said sample; sequentially collecting, with said optical assembly, electromagnetic radiation emanating from each of said sequentially illuminated volume elements, said optical assembly comprising at least one array of field stops whose dimensions are large compared to a quotient of wavelength of said electromagnetic radiation divided by a working numerical aperture of said optical assembly, measured from said field stops; and detecting the collected electromagnetic radiation emanating from each of said sequentially illuminated volume elements to produce a response representative of said characteristic in each of said volume elements. <IMAGE>
Patent JP-4153034-B2 (JP)
IPC: D21G1/02
Filed: 1996-04-18
Granted: 2008-09-17
Abstract: The invention concerns a system of oil feed ducts for a variable-crown roll, which roll (10) comprises a stationary roll axle (11) and a roll mantle (12) that is arranged revolving on said axle and that es supported on the roll axle (11) by means of hydraulic loading elements (13 1 ..13n) acting upon the inner face (12') of the roll mantle in the radi al direction, by means of which loading elements the axial profile of the roll mantle (12) can be regulated. Into the roll axle (11), an axial through hole (16) has been formed, which communicates with the cylinder bores (14 1...14n) or equivalent of the hydraulic loading elements (13 1...13n) through substantially radial bores (15 1...15n) or equivalent ducts (56a). In the axial through hole (16), at least through one of the roll (10) ends, at least oil feed pipes (21 1...21n) have been installed, through which pipes a pressure fluid is arranged to be fed to the hydraulic loading elements (13 1...13n). Into the axial through hole (16) in the roll axle (11), at the location of the loading elements (13 1...13n), an intermediate flange (53) or equivalent has been installed, which operates as a distributor piece, which is connected with the loading element (13 1...13n), and to which the oil feed pipe (21 1...21n) passing to the loading element isconnected so that, through said distributor piece, the pressure fluid can be passed to the loading (13t ..130), whereby the loading produced by means of said loading element (13 1...13n) i s adjustable in the desired way
Patent JP-3394049-B2 (JP)
IPC: B01L7/00
Filed: 1998-02-11
Granted: 2003-04-07
Abstract: The present invention relates to an improved microplate which is constructed of at least one frame part and at least one bottom part, where the bottom part has a maximum thickness of 500 mum.